JP2007535490A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007535490A5 JP2007535490A5 JP2006541588A JP2006541588A JP2007535490A5 JP 2007535490 A5 JP2007535490 A5 JP 2007535490A5 JP 2006541588 A JP2006541588 A JP 2006541588A JP 2006541588 A JP2006541588 A JP 2006541588A JP 2007535490 A5 JP2007535490 A5 JP 2007535490A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- monoclonal antibody
- another embodiment
- group
- derived
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52413103P | 2003-11-21 | 2003-11-21 | |
| US60/524,131 | 2003-11-21 | ||
| US55585704P | 2004-03-24 | 2004-03-24 | |
| US60/555,857 | 2004-03-24 | ||
| PCT/US2004/039071 WO2005052000A2 (en) | 2003-11-21 | 2004-11-19 | Anti-il-20 antibodies and binding partners and methods of using in inflammation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011212399A Division JP2012036204A (ja) | 2003-11-21 | 2011-09-28 | 抗ｉｌ−２０抗体および結合パートナーならびに炎症において用いる方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007535490A JP2007535490A (ja) | 2007-12-06 |
| JP2007535490A5 true JP2007535490A5 (https=) | 2011-03-03 |
| JP4991307B2 JP4991307B2 (ja) | 2012-08-01 |
Family
ID=34636508
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006541588A Expired - Fee Related JP4991307B2 (ja) | 2003-11-21 | 2004-11-19 | 抗ｉｌ−２０抗体および結合パートナーならびに炎症において用いる方法 |
| JP2006541597A Pending JP2007537993A (ja) | 2003-11-21 | 2004-11-19 | 抗ｉｌ−２０受容体抗体および結合パートナーならびに炎症において用いる方法 |
| JP2011212399A Pending JP2012036204A (ja) | 2003-11-21 | 2011-09-28 | 抗ｉｌ−２０抗体および結合パートナーならびに炎症において用いる方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006541597A Pending JP2007537993A (ja) | 2003-11-21 | 2004-11-19 | 抗ｉｌ−２０受容体抗体および結合パートナーならびに炎症において用いる方法 |
| JP2011212399A Pending JP2012036204A (ja) | 2003-11-21 | 2011-09-28 | 抗ｉｌ−２０抗体および結合パートナーならびに炎症において用いる方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20050170468A1 (https=) |
| EP (3) | EP1697418A2 (https=) |
| JP (3) | JP4991307B2 (https=) |
| AT (1) | ATE447587T1 (https=) |
| CA (2) | CA2542546A1 (https=) |
| DE (1) | DE602004023965D1 (https=) |
| ES (1) | ES2334140T3 (https=) |
| WO (2) | WO2005052001A2 (https=) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5945511A (en) * | 1997-02-20 | 1999-08-31 | Zymogenetics, Inc. | Class II cytokine receptor |
| US5965704A (en) * | 1997-08-05 | 1999-10-12 | Zymogenetics, Inc. | Class two cytokine receptor-11 |
| US6576743B1 (en) * | 1997-11-26 | 2003-06-10 | Zymogenetics, Inc. | Mammalian cytokine-like polypeptide-10 |
| US6610286B2 (en) * | 1999-12-23 | 2003-08-26 | Zymogenetics, Inc. | Method for treating inflammation using soluble receptors to interleukin-20 |
| US7122632B2 (en) * | 1999-12-23 | 2006-10-17 | Zymogenetics, Inc. | Soluble Interleukin-20 receptor |
| DE60123998T2 (de) * | 2000-08-08 | 2007-09-06 | Zymogenetics, Inc., Seattle | Lösliche zcyctor 11 cytokinrezeptoren |
| JP2007525438A (ja) * | 2003-03-24 | 2007-09-06 | ザイモジェネティクス， インコーポレイテッド | 抗ｉｌ−２２ｒａ抗体および結合パートナー、ならびに炎症における使用法 |
| AU2005299809B2 (en) * | 2004-10-22 | 2010-12-02 | Zymogenetics, Inc. | Anti-IL-22RA antibodies and binding partners and methods of using in inflammation |
| EP1856156A2 (en) * | 2005-02-08 | 2007-11-21 | ZymoGenetics, Inc. | Anti-il-20, anti-il-22 and anti-il-22ra antibodies and binding partners and methods of using in inflammation |
| US7611705B2 (en) * | 2007-06-15 | 2009-11-03 | National Cheng Kung University | Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases |
| BRPI0914916A2 (pt) * | 2008-06-30 | 2015-10-20 | Novo Nordisk As | anticorpos de interleucina-20 anti-humanos, assim como método de produção dos mesmos |
| US8012478B2 (en) * | 2008-10-07 | 2011-09-06 | National Cheng Kung University | Use of anti-IL-20 antibody for treating stroke |
| JP5860699B2 (ja) * | 2008-10-07 | 2016-02-16 | ナショナル チェン クン ユニバーシティ | 骨粗鬆症の治療のためのｉｌ−２０アンタゴニストの使用 |
| US7837994B2 (en) * | 2008-10-07 | 2010-11-23 | National Cheng Kung University | Use of anti-IL-20 antibody for treating osteoporosis |
| US8454956B2 (en) | 2009-08-31 | 2013-06-04 | National Cheng Kung University | Methods for treating rheumatoid arthritis and osteoporosis with anti-IL-20 antibodies |
| CN103052403B (zh) * | 2010-04-16 | 2014-10-22 | 成功大学 | 通过阻断il-20受体活性治疗与il-20受体介导的信号通路相关的病症 |
| US8535674B2 (en) | 2010-06-15 | 2013-09-17 | National Cheng Kung University | Treating breast cancer and inhibiting cancer-associated bone loss with anti-IL-20 antibody |
| WO2013117751A2 (en) | 2012-02-10 | 2013-08-15 | Novo Nordisk A/S | Methods related to treatment of inflammatory diseases and disorders |
| WO2013164440A1 (en) | 2012-05-03 | 2013-11-07 | Novo Nordisk A/S | Methods related to treatment of inflammatory diseases and disorders |
| WO2014006230A1 (en) * | 2012-07-06 | 2014-01-09 | Novo Nordisk A/S | Il-20 epitopes and il-20 ligands |
| WO2014015133A1 (en) * | 2012-07-19 | 2014-01-23 | National Cheng Kung University | Treatment of osteoarthritis using il-20 antagonists |
| US8852588B2 (en) * | 2012-08-07 | 2014-10-07 | National Cheng Kung University | Treating allergic airway disorders using anti-IL-20 receptor antibodies |
| US8603470B1 (en) | 2012-08-07 | 2013-12-10 | National Cheng Kung University | Use of IL-20 antagonists for treating liver diseases |
| WO2014093934A1 (en) * | 2012-12-14 | 2014-06-19 | Mindera Corporation | Methods and devices for detection and acquisition of biomarkers |
| US20140314741A1 (en) * | 2013-04-18 | 2014-10-23 | Developmen Center For Biotechnology | Human Antibody against Interleukin-20 and Treatment for Inflammatory Diseases |
| CN112961062A (zh) | 2014-04-04 | 2021-06-15 | 沙特基础工业全球技术有限公司 | 最小化乙醇胺产物流股中的水含量 |
| CN106164043A (zh) | 2014-04-08 | 2016-11-23 | 沙特基础工业全球技术有限公司 | 最小化乙醇胺产物流股中的水含量 |
| EP3148965A1 (en) | 2014-05-27 | 2017-04-05 | SABIC Global Technologies B.V. | Production of tea 85% directly without blending with pure cut of dea 99% |
| CN106414395A (zh) | 2014-05-30 | 2017-02-15 | 沙特基础工业全球技术有限公司 | 通过降低三乙醇胺塔处的温度改善乙醇胺产物流的质量和颜色 |
| PE20170441A1 (es) | 2014-06-06 | 2017-04-26 | Bristol Myers Squibb Co | Anticuerpos contra el receptor del factor de necrosis tumoral inducido por glucocorticoides (gitr) y sus usos |
| JP2017527262A (ja) * | 2014-07-03 | 2017-09-21 | イムノキュア アーゲーＩｍｍｕｎｏｑｕｒｅ Ａｇ | ヒト由来抗ｉｌ−２０抗体および抗サイトカイン抗体同定アッセイ |
| MX2017015260A (es) | 2015-06-03 | 2018-02-19 | Squibb Bristol Myers Co | Anticuerpos anti receptor de factor de necrosis tumoral inducible por glucocorticoide (gitr) para diagnostico del cancer. |
| AU2016356780A1 (en) | 2015-11-19 | 2018-06-28 | Bristol-Myers Squibb Company | Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof |
| WO2017202813A1 (en) * | 2016-05-24 | 2017-11-30 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of pulmonary bacterial infections |
| US9982043B2 (en) | 2016-06-03 | 2018-05-29 | National Cheng Kung University | Use of IL-20 antagonists for treating pancreatic cancer |
| US20180057564A1 (en) * | 2016-08-23 | 2018-03-01 | Clover Biopharmaceuticals | Antagonists of il-20 family of cytokines and their use |
| EP3615570A4 (en) | 2017-04-25 | 2021-02-24 | LBL Biotechnology Inc. | USE OF IL-20 ANTAGONISTS FOR TREATMENT OF EYE DISEASES |
| CN110869392A (zh) | 2017-05-16 | 2020-03-06 | 百时美施贵宝公司 | 用抗gitr激动性抗体治疗癌症 |
| JP7258329B2 (ja) * | 2018-09-01 | 2023-04-17 | 国立大学法人神戸大学 | 連続式振動流バッフル反応装置及び反応法 |
| JP7588139B2 (ja) | 2019-09-04 | 2024-11-21 | インサーム（インスティテュ ナシオナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシェ メディカル） | 慢性閉塞性肺疾患の急性増悪の処置のためのｉｌ２０－ｒｂに特異的な抗体及びその使用 |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5208021A (en) * | 1987-10-05 | 1993-05-04 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method of preparing diphtheria immunotoxins |
| US5567584A (en) * | 1988-01-22 | 1996-10-22 | Zymogenetics, Inc. | Methods of using biologically active dimerized polypeptide fusions to detect PDGF |
| US20020099179A1 (en) * | 1989-12-21 | 2002-07-25 | Linda K. Jolliffe | Cdr-grafted antibodies |
| US5436155A (en) | 1991-12-31 | 1995-07-25 | Arch Development Corporation | Isolated DNA encoding a somatostatin receptor |
| US5789192A (en) | 1992-12-10 | 1998-08-04 | Schering Corporation | Mammalian receptors for interleukin-10 (IL-10) |
| GB2315386B (en) | 1996-07-13 | 2000-10-18 | Motorola Ltd | Improved flow control in cellular radio networks |
| US5985614A (en) * | 1996-08-30 | 1999-11-16 | Human Genome Sciences, Inc. | Polynucleotides encoding interleukin-19 |
| EP2065396A1 (en) | 1996-08-30 | 2009-06-03 | Human Genome Sciences, Inc. | Interleukin-19 |
| DE19650541C2 (de) | 1996-12-05 | 1999-05-12 | Siemens Ag | Verfahren zur Ermittlung eines ersten Referenzschriftzugs anhand mehrerer Musterschriftzüge |
| US5945511A (en) | 1997-02-20 | 1999-08-31 | Zymogenetics, Inc. | Class II cytokine receptor |
| WO2000078961A1 (en) | 1999-06-23 | 2000-12-28 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| EP0979102A4 (en) * | 1997-04-30 | 2005-11-23 | Enzon Inc | DETAILED POLYPEPTIDE MODIFIED BY POLYALKYLENE OXIDE |
| US6486301B1 (en) | 1997-07-16 | 2002-11-26 | Human Genome Sciences, Inc. | Interleukin-20 |
| JP2001510035A (ja) | 1997-07-16 | 2001-07-31 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | インターロイキン−２０ |
| US5965704A (en) | 1997-08-05 | 1999-10-12 | Zymogenetics, Inc. | Class two cytokine receptor-11 |
| WO1999007740A2 (en) | 1997-08-06 | 1999-02-18 | Zymogenetics, Inc. | Lipocalin homologs |
| IL136076A0 (en) * | 1997-11-26 | 2001-05-20 | Zymogenetics Inc | Mammalian cytokin-like polypeptide -10 |
| US6576743B1 (en) * | 1997-11-26 | 2003-06-10 | Zymogenetics, Inc. | Mammalian cytokine-like polypeptide-10 |
| EP1047781B1 (en) | 1998-01-23 | 2004-07-28 | Immunex Corporation | Il-18 receptors |
| WO1999046379A2 (en) | 1998-03-09 | 1999-09-16 | Schering Corporation | Human receptor proteins; related reagents and methods |
| US6586228B1 (en) | 1998-03-09 | 2003-07-01 | Schering Corporation | Polynucleotides encoding DIRS1 |
| ES2312205T3 (es) | 1998-03-10 | 2009-02-16 | Genentech, Inc. | Nuevo polipeptido y acidos nucleicos que lo codifican. |
| US6982320B2 (en) | 1998-03-19 | 2006-01-03 | Human Genome Sciences, Inc. | Cytokine receptor common gamma chain like |
| AU5203199A (en) | 1998-05-26 | 1999-12-13 | Procter & Gamble Company, The | Chimeric molecules comprising an extracellular ligand binding domain of a receptor and an ige fc or constant region, and their use in an assay system |
| NZ531664A (en) | 1998-09-01 | 2005-07-29 | Genentech Inc | Pro1317 polypeptides and sequences thereof with homology to the semaphorin B glycoprotein family |
| ES2221759T3 (es) | 1998-11-25 | 2005-01-01 | Zymogenetics, Inc. | Zace1: una metaloenzima humana. |
| EP1141008A1 (en) | 1998-12-31 | 2001-10-10 | Millennium Pharmaceuticals, Inc. | Class ii cytokine receptor-like proteins and nucleic acids encoding them |
| AU5047600A (en) | 1999-05-27 | 2000-12-18 | Schering Corporation | Mammalian interleukin-10 homologs: il-d110 and il-d210 |
| AU2253301A (en) | 1999-12-03 | 2001-06-12 | Zymogenetics Inc. | Human cytokine receptor |
| EP1244708B8 (en) * | 1999-12-23 | 2007-03-07 | ZymoGenetics, Inc. | Method for treating inflammation |
| US6610286B2 (en) | 1999-12-23 | 2003-08-26 | Zymogenetics, Inc. | Method for treating inflammation using soluble receptors to interleukin-20 |
| DE60123998T2 (de) | 2000-08-08 | 2007-09-06 | Zymogenetics, Inc., Seattle | Lösliche zcyctor 11 cytokinrezeptoren |
| ATE333888T1 (de) * | 2000-09-15 | 2006-08-15 | Zymogenetics Inc | Verwendung eines polypeptids, welches die extrazelluläre domäne von il-20ra und il-20rb enthält, zur behandlung von entzündungen |
| EP1390060A2 (en) | 2001-01-26 | 2004-02-25 | Eli Lilly And Company | Use of lp82 to treat body weight disorders |
| CA2433933A1 (en) | 2001-02-28 | 2002-09-12 | Eli Lilly And Company | Use of lp82 to treat hematopoietic disorders |
| EP1399472B1 (en) | 2001-03-09 | 2009-06-03 | ZymoGenetics, Inc. | Soluble heterodimeric cytokine receptor |
| DE10154579A1 (de) | 2001-11-07 | 2003-05-28 | Medigene Ag | Topikale Verwendung von Cytokinen und Chemokinen zur Behandlung von viralen oder mykotischen Hauterkrankungen oder Tumorerkrankungen |
| CA2467723C (en) | 2001-12-17 | 2011-09-27 | Zymogenetics, Inc. | Method for treating cervical cancer |
| AU2003223344B9 (en) | 2002-03-22 | 2009-07-16 | Zymogenetics, Inc. | Anti-IL-TIF antibodies and methods of using in inflammation |
| JP2004121218A (ja) * | 2002-08-06 | 2004-04-22 | Jenokkusu Soyaku Kenkyusho:Kk | 気管支喘息または慢性閉塞性肺疾患の検査方法 |
| JP4053444B2 (ja) * | 2003-03-07 | 2008-02-27 | シャープ株式会社 | 携帯可能な多機能電子機器 |
| JP2007525438A (ja) * | 2003-03-24 | 2007-09-06 | ザイモジェネティクス， インコーポレイテッド | 抗ｉｌ−２２ｒａ抗体および結合パートナー、ならびに炎症における使用法 |
| AU2005299809B2 (en) * | 2004-10-22 | 2010-12-02 | Zymogenetics, Inc. | Anti-IL-22RA antibodies and binding partners and methods of using in inflammation |
| JP2008106946A (ja) * | 2005-02-10 | 2008-05-08 | Matsushita Electric Ind Co Ltd | 冷凍サイクル装置 |
| JP2010502224A (ja) * | 2006-09-08 | 2010-01-28 | アボット・ラボラトリーズ | インターロイキン１３結合タンパク質 |
| BRPI0914916A2 (pt) * | 2008-06-30 | 2015-10-20 | Novo Nordisk As | anticorpos de interleucina-20 anti-humanos, assim como método de produção dos mesmos |
-
2004
- 2004-11-19 WO PCT/US2004/039097 patent/WO2005052001A2/en not_active Ceased
- 2004-11-19 US US10/994,151 patent/US20050170468A1/en not_active Abandoned
- 2004-11-19 US US10/994,116 patent/US7393684B2/en not_active Expired - Lifetime
- 2004-11-19 DE DE602004023965T patent/DE602004023965D1/de not_active Expired - Lifetime
- 2004-11-19 CA CA002542546A patent/CA2542546A1/en not_active Abandoned
- 2004-11-19 AT AT04811735T patent/ATE447587T1/de active
- 2004-11-19 EP EP04811758A patent/EP1697418A2/en not_active Withdrawn
- 2004-11-19 WO PCT/US2004/039071 patent/WO2005052000A2/en not_active Ceased
- 2004-11-19 EP EP04811735A patent/EP1692180B1/en not_active Expired - Lifetime
- 2004-11-19 JP JP2006541588A patent/JP4991307B2/ja not_active Expired - Fee Related
- 2004-11-19 CA CA002545867A patent/CA2545867A1/en not_active Abandoned
- 2004-11-19 EP EP09174247A patent/EP2143733A1/en not_active Withdrawn
- 2004-11-19 ES ES04811735T patent/ES2334140T3/es not_active Expired - Lifetime
- 2004-11-19 JP JP2006541597A patent/JP2007537993A/ja active Pending
-
2008
- 2008-05-21 US US12/124,946 patent/US8907068B2/en active Active
-
2011
- 2011-09-28 JP JP2011212399A patent/JP2012036204A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007535490A5 (https=) | ||
| CY2019029I2 (el) | Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις | |
| LTC2567976I2 (lt) | Antikūnai prieš CD38 antigeną, skirti išsėtinės mielomos gydymui | |
| EP1607404A4 (en) | MONOCLONAL ANTIBODY AND HYBRIDOM THAT PRODUCES THIS | |
| LTPA2018007I1 (lt) | Anti-IL-12 antikūnai, kompozicijos, būdai ir panaudojimas | |
| DK1578397T3 (da) | Humane monoklonale antistoffer mod CD25 | |
| CY2012019I1 (el) | Ανθρωπινα μονοκλωνα αντισωματα εναντια στο cd20 | |
| IL184152A (en) | Monoclonal antibodies against nkg2a, preparations containing them, their use in drug preparation, methods of manufacture, and methods used in | |
| JP2012507294A5 (https=) | ||
| JP2005526058A5 (https=) | ||
| TW200636064A (en) | Anti-respiratory syncytial virus antibodies, antigens and uses thereof | |
| DE60222658D1 (de) | Monoklonaler anti-cd-40-antikörper | |
| NL1027975A1 (nl) | Antilichamen tegen MAdCAM. | |
| CY2014038I2 (el) | Αντι-il-6 αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
| SI1704166T1 (sl) | M-scf specifiäśno monoklonsko protitelo in uporabe le-tega | |
| EP1448787A4 (en) | HUMAN MONOCLONAL ANTIBODIES DIRECTED AGAINST DENDRITIC CELLS | |
| ATE517340T1 (de) | Sätze gegen kurze epitope gerichteter digitaler antikörper sowie diese verwendende verfahren | |
| JP2007525465A5 (https=) | ||
| JP2005516606A5 (https=) | ||
| ITRM20040586A1 (it) | Epitopi antigenici dell'interleuchina-21, anticorpi relativi e loro uso in campo medico. | |
| ITRM20040105A1 (it) | Anticorpo monoclonale antitenascina umana. | |
| JP2005536763A5 (https=) | ||
| JP2004526429A5 (https=) | ||
| FI20011055A0 (fi) | Heveiiniä sitovat monoklonaaliset vasta-aineet | |
| DK1503799T3 (da) | Immunogent, monoklonalt antistof |